117 related articles for article (PubMed ID: 2148055)
21. Plasmin inhibition of platelet function and of arachidonic acid metabolism.
Schafer AI; Adelman B
J Clin Invest; 1985 Feb; 75(2):456-61. PubMed ID: 3156149
[TBL] [Abstract][Full Text] [Related]
22. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
[TBL] [Abstract][Full Text] [Related]
23. Plasmin inhibition of thrombin-induced platelet aggregation.
Miller JL; Katz AJ; Feinstein MB
Thromb Diath Haemorrh; 1975 Apr; 33(2):286-309. PubMed ID: 124475
[TBL] [Abstract][Full Text] [Related]
24. Plasmin-mediated activation of platelets occurs by cleavage of protease-activated receptor 4.
Quinton TM; Kim S; Derian CK; Jin J; Kunapuli SP
J Biol Chem; 2004 Apr; 279(18):18434-9. PubMed ID: 14973136
[TBL] [Abstract][Full Text] [Related]
25. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE
Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379
[TBL] [Abstract][Full Text] [Related]
26. Plasmin-platelet interaction involves cleavage of functional thrombin receptor.
Kimura M; Andersen TT; Fenton JW; Bahou WF; Aviv A
Am J Physiol; 1996 Jul; 271(1 Pt 1):C54-60. PubMed ID: 8760030
[TBL] [Abstract][Full Text] [Related]
27. Characterization of plasmin-induced platelet aggregation.
Watabe A; Ohta M; Matsuyama N; Mizuno K; el Borai N; Tanimoto T; Kawanishi T; Hayakawa T
Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):341-52. PubMed ID: 9261893
[TBL] [Abstract][Full Text] [Related]
28. Temperature dependence of plasmin-induced activation or inhibition of human platelets.
Lu H; Soria C; Cramer EM; Soria J; Maclouf J; Perrot JY; Li H; Commin PL; Schumann F; Regnier O
Blood; 1991 Mar; 77(5):996-1005. PubMed ID: 1825290
[TBL] [Abstract][Full Text] [Related]
29. In vitro effect of plasmin on human platelet function in plasma. Inhibition of aggregation caused by fibrinogenolysis.
Gouin I; Lecompte T; Morel MC; Lebrazi J; Modderman PW; Kaplan C; Samama MM
Circulation; 1992 Mar; 85(3):935-41. PubMed ID: 1531623
[TBL] [Abstract][Full Text] [Related]
30. Platelet activation and subsequent inhibition by plasmin and recombinant tissue-type plasminogen activator.
Penny WF; Ware JA
Blood; 1992 Jan; 79(1):91-8. PubMed ID: 1530814
[TBL] [Abstract][Full Text] [Related]
31. Contribution of PAR-1, PAR-4 and GPIbalpha in intracellular signaling leading to the cleavage of the beta3 cytoplasmic domain during thrombin-induced platelet aggregation.
Dubois C; Steiner B; Meyer Reigner SC
Thromb Haemost; 2004 Apr; 91(4):733-42. PubMed ID: 15045135
[TBL] [Abstract][Full Text] [Related]
32. Effects of plasmin on rabbit platelets.
Guccione MA; Kinlough-Rathbone RL; Packham MA; Harfenist EJ; Rand ML; Greenberg JP; Perry DW; Mustard JF
Thromb Haemost; 1985 Feb; 53(1):8-14. PubMed ID: 3158094
[TBL] [Abstract][Full Text] [Related]
33. High-molecular-mass and low-molecular-mass kininogens block plasmin-induced platelet aggregation by forming a complex with kringle 5 of plasminogen/plasmin.
Selim TE; Ghoneim HR; Uknis AB; Colman RW; DeLa Cadena RA
Eur J Biochem; 1997 Dec; 250(2):532-8. PubMed ID: 9428707
[TBL] [Abstract][Full Text] [Related]
34. Platelet protein phosphorylation, elevation of cytosolic calcium, and inositol phospholipid breakdown in platelet activation induced by plasmin.
Schafer AI; Maas AK; Ware JA; Johnson PC; Rittenhouse SE; Salzman EW
J Clin Invest; 1986 Jul; 78(1):73-9. PubMed ID: 3013942
[TBL] [Abstract][Full Text] [Related]
35. Investigation of the role of calpain as a stimulus-response mediator in human platelets using new synthetic inhibitors.
Anagli J; Hagmann J; Shaw E
Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):497-502. PubMed ID: 2006912
[TBL] [Abstract][Full Text] [Related]
36. Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets.
Fox JE; Austin CD; Reynolds CC; Steffen PK
J Biol Chem; 1991 Jul; 266(20):13289-95. PubMed ID: 2071604
[TBL] [Abstract][Full Text] [Related]
37. Exposure of human platelets to plasmin results in the expression of irreversibly active fibrinogen receptors.
Rabhi-Sabile S; Pidard D
Thromb Haemost; 1995 Apr; 73(4):693-701. PubMed ID: 7495081
[TBL] [Abstract][Full Text] [Related]
38. Plasmin-induced platelet aggregation and platelet release reaction. Effects on hemostasis.
Niewiarowski S; Senyi AF; Gillies P
J Clin Invest; 1973 Jul; 52(7):1647-59. PubMed ID: 4268896
[TBL] [Abstract][Full Text] [Related]
39. Thrombin- and cathepsin G-induced platelet aggregation: effect of protein kinase C inhibitors.
Puri RN; Colman RW
Anal Biochem; 1993 Apr; 210(1):50-7. PubMed ID: 7683848
[TBL] [Abstract][Full Text] [Related]
40. Vinculin is proteolyzed by calpain during platelet aggregation: 95 kDa cleavage fragment associates with the platelet cytoskeleton.
Serrano K; Devine DV
Cell Motil Cytoskeleton; 2004 Aug; 58(4):242-52. PubMed ID: 15236355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
